5 results for " ISSN:"1170-7690" AND Volume:24 AND PageRange:21 "   Not what you’re looking for? Try Advanced Search

Sociodemographic differences in quality of life in rheumatoid arthritis.

Groessl, Erik J.;  Ganiats, Theodore G.;  Sarkin, Andrew J.
PharmacoEconomics. Volume 24; Issue 2; Pages 109-21; 2006
Type:   Journal Article;  Research Support, U.S. Gov't, Non-P.H.S.;  Review

Assessment of health-related quality of life (HR-QOL) in people with rheumatoid arthritis (RA) has become important in health research and can inform clinical care. Many studies have found sociodemographic differences in the HR-QOL of people with RA,...
 Abstract


Is the childhood asthma questionnaire a good measure of health-related quality of life of asthmatic children in Asia?: validation among paediatric patients with asthma in Singapore.

Chong, Lee-Yee;  Chay, Oh-Moh;  Shu-Chuen, Li
PharmacoEconomics. Volume 24; Issue 6; Pages 609-21; 2006
Type:   Journal Article;  Research Support, Non-U.S. Gov't;  Validation Studies

Health-related quality of life (HR-QOL) is an important outcome in the treatment of chronic childhood diseases such as asthma. However, this measure is rarely used in young children in Asia because of the difficulty of obtaining valid, reliable instr...
 Abstract


Costs of irritable bowel syndrome in the UK and US.

Maxion-Bergemann, Stefanie;  Thielecke, Frank;  Abel, Florian;  Bergemann, Rito
PharmacoEconomics. Volume 24; Issue 1; Pages 21-37; 2006
Type:   Journal Article;  Research Support, Non-U.S. Gov't;  Review

Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, with an estimated prevalence rate in the general population of 10-15% in industrialised countries. Although IBS is not a life-threatening disease, it cont...
 Abstract


Cost-effectiveness of Rosiglitazone Combination Therapy for the Treatment of Type 2 Diabetes Mellitus in the UK

Beale, Sophie;  Bagust, Adrian;  Shearer, Arran;  Martin, Alan;  Hulme, Lisa
PharmacoEconomics. Volume 24; Pages 21–34; 2006
Type:   Article

Abstract Introduction: Recent clinical trial results have demonstrated that, in patients with type 2 diabetes, second-line treatment of rosiglitazone in combination with metformin can lead to significant improvements in the control of fasting plasma ...
 Abstract


Costs of Irritable Bowel Syndrome in the UK and US

Maxion-Bergemann, Stefanie;  Thielecke, Frank;  Abel, Florian;  Bergemann, Rito
PharmacoEconomics. Volume 24; Issue 1; Pages 21-37; 2006
Type:   Review

Abstract Irritable bowel syndrome (IBS) is one of the most common functional gastrointestinal disorders, with an estimated prevalence rate in the general population of 10–15% in industrialised countries. Although IBS is not a life-threatening disease...
 Abstract